Marie-Hélène Leblanc

Author

Also Known As

M H Leblanc, M H. Leblanc, M LEBLANC, M. H. Leblanc, M. Leblanc, M.H. LeBlanc, Marie Hélène Leblanc, Marie-Helene LeBlanc, Marie-Helene Leblanc, Marie-Hélène LeBlanc

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Montreal Heart Institute Institut universitaire de cardiologie et de pneumologie de Québec Université Laval Université de Montréal University of Ottawa

About

Marie-Hélène Leblanc is an author at Montreal Heart Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	909
2	Public Health	3	3	70
3	Health Sciences	2	2	89
4	Engineering	1	1	68
5	Applied Physiology	1	1	27

Marie-Hélène Leblanc

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis Eileen O’Meara, Michael McDonald, Michael Chan, Canadian Journal of Cardiology CardiomyopathyHeart FailureCardiorenal SyndromesCardiovascular DiseaseStructural Heart Disease	2020	120
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications Gordon W. Moe, Justin A. Ezekowitz, Eileen O’Meara, Canadian Journal of Cardiology Heart FailureCardiovascular DiseaseCardiac CarePreventive CardiologyMedicine	2014	110
Basiliximab and Rabbit Anti-thymocyte Globulin for Prophylaxis of Acute Rejection After Heart Transplantation: A Non-inferiority Trial Michel Carrier, Marie-Hélène Leblanc, Louis P. Perrault, The Journal of Heart and Lung Transplantation Heart FailureTransplantationHematologyImmunologyAcute Rejection	2007	78
Hemodynamic features of the freestyle aortic bioprosthesis compared with stented bioprosthesis Jean G. Dumesnil, Marie-Hélène Leblanc, P Cartier, The Annals of Thoracic Surgery MechanobiologyStented BioprosthesisEngineeringVascular AdaptationBiomechanics	1998	68
Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study Julius M. Gardin, Eric Leifer, Jerome L. Fleg, American Heart Journal Heart FailureKinesiologyPhysical ActivityCardiovascular DiseaseSystolic Heart Failure	2009	62
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4 Marie‐Odile Benoit‐Biancamano, Jean‐Philippe Adam, Olivier Bernard, Pharmacogenetics and Genomics	2009	58
Enalapril versus digoxin in patients with congestive heart failure: A multicenter study Richard F. Davies, Donald S. Beanlands, Claude Nadeau, Journal of the American College of Cardiology Heart FailureCardiogenic ShockCardiovascular DiseaseCardiovascular PharmacologyPharmacotherapy	1991	50
Effects of Combined Candesartan and ACE Inhibitors on BNP, Markers of Inflammation and Oxidative Stress, and Glucose Regulation in Patients With Symptomatic Heart Failure Michel White, Serge Lepage, Joël Lavoie, Journal of Cardiac Failure Metabolic SyndromeHypertensionHeart FailureAce InhibitorsCombined Candesartan	2007	45
Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation J. Lluch Pons, Marie-Hélène Leblanc, Mathieu Bernier, The Journal of Heart and Lung Transplantation Pulmonary Arterial HypertensionHeart FailureTransplantationChronic Sildenafil UseCardiovascular Disease	2012	44

Page 1